Review of nemonoxacin with special focus on clinical development
Xiaohua Qin, Haihui Huang Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, People's Republic of China Abstract: Nemonoxacin is a novel C-8-methoxy nonfluorinated quinolone with remarkably enhanced in vitro activity against a wide variety of clinically relevant pathog...
Main Authors: | Qin X, Huang H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-07-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/review-of-nemonoxacin-with-special-focus-on-clinical-development-peer-reviewed-article-DDDT |
Similar Items
-
Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia
by: Zhao B, et al.
Published: (2020-07-01) -
Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers
by: Zhang YF, et al.
Published: (2016-01-01) -
Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against Streptococcus Pneumoniae
by: Xin Li, et al.
Published: (2021-05-01) -
Tentative clinical breakpoints and epidemiological cut-off values of nemonoxacin for Streptococcus pneumoniae and Staphylococcus aureus isolates associated with community-acquired pneumonia
by: Shio-Shin Jean, et al.
Published: (2020-12-01) -
The efficacy and safety of nemonoxacin compared with levofloxacin in the treatment of community-acquired pneumonia: a systemic review and meta-analysis of randomized controlled trials
by: Chang SP, et al.
Published: (2019-02-01)